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cine to prepare anti-H5N1 IgGs. The F(ab’)2 fragments were
puriﬁed from anti-H5N1 hyperimmune sera by a protocol for
’enhanced pepsin digestion’. The protective effect of the F(ab’)2
fragments against H5N1 virus infection was determined in cul-
tured MDCK cells by cytopathic effect (CPE) assay and in a BALB/c
mouse model by survival rate assay.
Results: By the protocol for “enhanced pepsin digestion”, total
16 g F(ab’)2 fragments were ﬁnally obtained from one liter
equine antisera with the purity of over 90%. The H5N1-speciﬁc
F(ab’)2 fragments had a HI titer of 1:1024, and the neutralization
titre of F(ab’)2 reached 1:2048. The in vivo assay showed that
100 μg of the F(ab’)2 fragments could protect BALB/c mice
infected with a lethal dose of inﬂuenza H5N1 virus.
Conclusion: The availability of highly puriﬁed H5N1-speciﬁc
F(ab’)2 fragments may be promising for treatment of inﬂuenza
H5N1 infection. Our work has provided experimental support
for the application of the therapeutic equine immunoglobulin in
future large primate or human trials.
OL-044 Molecular evolution of H9N2 inﬂuenza A viruses
in Eastern China (1996 to 2008): implications for
the origin of highly pathogenic H5N1 viruses
Pinghu Zhang*,1,2, Xiufan Liu1, Yinghua Tang1, Xiaowen Liu1,
Wenbo Liu1, Xiaorong Zhang1, Hongqi Liu1, Daxin Peng1,
Song Gao1, Yantao Wu1, Shan Lu3,4. 1Animal Infectious Disease
Laboratory, College of Veterinary Medicine, Yangzhou
University; 2New Drug Screening Center, China Pharmaceutical
University; 3The First Afﬁliated Hospital of Nanjing Medical
University; 4University of Massachusetts Medical School,
Worcester, MA, USA
Background: Since it was ﬁrst isolated in Southern China in 1992,
H9N2 avian inﬂuenza virus has caused signiﬁcant economic loss in
China and is transmitted to humans and other animals. Currently,
H5N1 avian inﬂuenza virus have resulted in 285 deaths of 364
diagnosed humans cases. However, the precursors of these H5N1
inﬂuenza viruses are yet to be determined.
Methods: We analyzed the antigenic and genetic features of
H9N2 inﬂuenza viruses isolated from poultry in Eastern China
from 1996 to 2008.
Results: Phylogentic analysis revealed 6 genotypes, includ-
ing 4 novel genotypes that have not been recognized be-
fore. The major H9N2 inﬂuenza viruses represented by
A/Chiken/Beijing/1/1994 (Ck/BJ/1/94)-like viruses circulating
in poultry in eastern China before 1998 were gradually replaced
by A/Chicken/Shanghai/F/1998 (Ck/SH/F/98)-like viruses, which
contained RNP complex genes genetically highly related to H5N1
inﬂuenza virus, since1998. The similarity of the RNP genes in
Ck/SH/F/98-like viruses to those of the human and poultry H5N1
inﬂuenza viruses isolated from 2001 onwards circulating in Eura-
sia suggests that the Ck/SH/F/98 virus may have been the donor
of internal genes of these H5N1 viruses.
Conclusion: Our study provides new insights into the genesis and
evolution of H9N2 inﬂuenza viruses and provides new evidence
for the origin of H5N1 inﬂuenza viruses.
OL-045 The establishment of real-time ﬂuorescent
quantitative polymerase chain reaction (PCR) for
detection of highly pathogenic Avian inﬂuenza
virus subtype H5N1
Changran Zhang*,1, Yuanyuan Niu1, Xiaoyuan Liu1,
Kaiquan Zhou2, Jiancong Lin1, Ming Li 1, Xiaohua Luo2.
1Department of Internal Medicine, Huang Pu Hospital of the
First Afﬁliated Hospital, Sun Yat-sen University; 2The Huang Pu
Center of Disease Control and Prevention (CDC)
Background: Highly pathogenic strains of avian inﬂuenza virus
(AIV), which are inﬂuenza A viruses, cause severe disease in
domestic poultry and humans. The objective of this study was to
establish a ﬂuorescent quantitative RT-PCR assay for detection of
highly pathogenic avian inﬂuenza virus (AIV) subtype H5N1.
Methods: The H5 and N1 subtype-speciﬁc probe sets were de-
veloped based on avian inﬂuenza virus sequences detected in
China. Two pairs of primers and two ﬂuorescent probes were
strictly designed and optimized in a reaction system. According
to the amount of plasmid RNA extracted from H5N1 strains, the
standard curve DWQBGWDWQBGW of ﬂuorescent quantitative
PCR was drawn and all of the specimens were then tested by
means of Real-time PCR.
Results: The standard avian inﬂuenza A virus/H5N1 panel ap-
peared positive (10/10, 100%), which demonstrated by virus
isolation (VI). H9N2 and H3N2 were all negative (10/10, 100%);
Newcastle disease virus (NDV), infectious bronchitis virus (IBV),
infectious bursal disease virus (IBDV), egg drop syndrome virus
(EDSV), and the blank control were all negative (10/10, 100%).
11 sick or dying chickens, which were diagnosed AIV, appeared
positive (10/11, 90.9%); 65 staffs’ throat swab samples also were
collected who worked as sellers of chickens in the bird markets
were all negative (0/65,0%). The assay was easy to carry out and
highly reproducible.
Conclusion: Fluorescent quantitative PCR, described here, pro-
vides a rapid, speciﬁc and sensitive method to detect not only
the H5 but N1 genes as well, in particular, during outbreaks of
H5N1 inﬂuenza A virus.
OL-046 Comparative study of rapid test with standard
method RT-PCR for detection of inﬂuenza A virus
infection in suspected cases admitted at
Khonkaen Hospital, Thailand during 2005–2007
Pairoj Wechagama*, Wisansanee Thaewpia, Rinjong Promsorn,
Sompong Jinathongthai. Clinical Pathology Laboratory
Department, Khon Kaen Hospital, Khon Kaen, Thailand
Objectives: To assess the performance and effectiveness of rapid
test; Clearview Exact Inﬂuenza A&B (Binax, UK) for detection of
inﬂuenza A virus in nasopharygneal swab by using RT-PCR as the
standard method.
Method: Patients with a inﬂuenza-like illness admitted at Khon
Kaen Hospital between January 1, 2005, and October 31, 2007,
were considered for this study. Samples were collected with
informed consent. In total, 50 suspected cases with nasopha-
ryngeal swab samples were available for the study. The clinical
beneﬁt of the rapid test was evaluated by comparing the results
with standard method RT-PCR.
Result: The prevalences of inﬂuenza A positive in 50 cases
measured by rapid test and RT-PCR are 23.8% and 66.7%. The sen-
sitivity, speciﬁcity, positive predictive value, negative predictive
value and prevalence are 83.33% (95%CI 51.5-91.9), 100% (95%CI
88.4-100), 100% (95%CI 69.1-100), 93.75% (95%CI 79.2-99.2) and
28.57% (95%CI 15.7-44.6) respectively.
Conclusion: The ﬁnding that the sensitivity of rapid test was
slightly low when compared with standard method RT-PCR. There
may depend on many factors including the method of specimen
collection, the test method used, geographic location, and the
disease prevalence in speciﬁc localities. In addition, the impor-
tant properties of diagnostic tests that need to considered are
analytical sensitivity and analytical speciﬁcity.
OL-047 A combinatorial antiviral approach against
inﬂuenza A virus using ribozyme and siRNA
Madhu Khanna*,1,2, Vikas Sood3, Akhil Banerjea3,
Prashant Kumar3. 1VP Chest Institute; 2University of Delhi;
3National Institute of Immunology, New Delhi
Background: Recent advances in antisense technology have
emerged as a ray of hope against many pathogens. Latest fad
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being siRNAs, but still has its own limitations like silencing off
targets and no access to nuclear genes. Hence among alterna-
tives, catalytic nucleic acids are the best candidates to bet upon.
The aim of this study is to use the catalytic nucleic acids like
Ribozymes and DNAzymes as a candidate to have a control on the
replication of inﬂuenza virus in the host cells.
Methods: The M1 gene of A/PR/8/34 (H1N1)) strains were cloned
in pcDNA 3. The computer based secondary structures of RNA
were analyzed to design the DNAzymes with 10-23 catalytic
motifs and the hammerhead Ribozymes. The DNAzymes and
Ribozymes were also used in combination.
Results: The DNAzymes were able to cleave the M1 RNA at 137
nt position whereas Ribozymes targeted at163 nt position in the
same target. These catalytic nucleic acids were highly efﬁcient
under the simulated physiological conditions. When DNAzymes
and Ribozymes were used in combination the cleavage was en-
hanced as compared to when they were used alone. Further
an siRNA-Ribozyme construct was also designed. We have also
demonstrated the modulation of the expression of target gene in
controlled manner at RNA level by RT-PCR and FACs.
Conclusion: This combinatorial strategy can be used to de-
sign multi target DNA-enzymes and Ribozymes to delay the
appearance of escape mutants because of the low probability of
simultaneous mutations in both the target RNA sites.
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OL-048 P-glycoprotein regulation in Hep3B cells by
polyprenol could decrease the risk of
hepatocarcinogenesis in HBV
Sergejs Kuznecovs*, Ivans Kuznecovs. Cancer Research
Laboratory
Background: Over-expression of P-glycoprotein (Pgp) is associ-
ated with liver cancer development from HBV. The resent results
are also in favour of the idea that glycoprotein synthesis in ma-
lignant tissues is limited by Dolichyl Phosphate (DolP). The aim of
the present study was to investigate the effect of polyprenol (PP)
which provides a DolP substitute in regulation of N-glycosylation
on Pgp over-expression in the development of liver cancer in HBV
infection.
Methods: Human hepatocytes, infected with HBV and human
hepatocarcinoma HEP 3B cell line were used. Pgp was assessed
by an immunohistochemical technique. DolP fractions were anal-
ysed by HPLC methods.
Result: It is conﬁrmed that plasmatic membrans of hepatocytes-
cells contain 7,9–9,4% of Pgp (the total protein amount) as a
resistance marker. HBV infected cells differ from normal hepato-
cytes in Pgp content by 4-5 times and Hep3B cells differ by 10-12
times The study showed 5-fold DolP decrease in HBV infected
cells and 10-fold DolP decrease in Hep3B cells. The investigations
demonstrate that the situation can be changed by treatment with
DolP and PP. The DolP concentration in HBV infected hepatocytes
was returned to the normal level. It is established that DolP in
the concentration 10-6M aid 6-8-fold reducing Pgp in membranes
of HBV infected cells.
Conclusion: These results indicate that noncontrollable accu-
mulation of Pgp in HBV infected cells can be overcomed using
stimulation with DolP substitution. Polyprenol usage can open up
possibilities in liver cancer prevention in HBV infection.
OL-049 T cell immunoglobulin- and
mucin-domain-containing molecule-3 (Tim-3)
mediates natural killer cell suppression in
chronic hepatitis B
Ying Ju*,1, Nan Hou1, Jing Meng1, Xiaoyan Wang1,
Xiaoning Zhang1, Xiaoyan Wang2, Jinjin Wang1, Fang Luan1,
Wei Shi 1, Faliang Zhu1, Chun Guo1, Lining Zhang1,
Wensheng Sun1, Xiaohong Liang1, Lifen Gao1, Chunhong Ma1,3.
1Institute of Immunology; 2Infectious Disease Hospital; 3The Key
Laboratory for Experimental Teratology of the Ministry of
Education
Background/Aims: T cell immunoglobulin- and mucin-domain-
containing molecule-3 (Tim-3) has been shown to inﬂuence
autoimmune diseases, including diabetes and multiple sclerosis,
but its role in viral infection has not been well-deﬁned. In this
study, we investigated the expression and regulatory function of
Tim-3 on natural killer (NK) cells in chronic Hepatitis B (CHB).
Methods: Seventy-six CHB patients, 38 healthy controls, and
18 patients with fatty liver disease (FLD) were studied. Tim-3
expression was detected in both peripheral blood mononuclear
cells (PBMCs) and liver inﬁltrating lymphocytes (LILs) by real-
time RT-PCR, ﬂow cytometric analysis and immunohistochemical
analysis. The roles of Tim-3 in NK cell were detected by ﬂow
cytometric analysis and cytotoxicity assay.
Results: We found the increased Tim-3 expression in PBMCs, LILs
and circulating NK cells from CHB. Increased Tim-3 expression
was also detected on cultured NK92 cells transfected with HBV
expression vector (pCDNA-1.1HBV) and hepatic NK cells from
HBV transgenic mice. Importantly, upon blocking Tim-3 with
a speciﬁc antibody, NK92 cells showed increased cytotoxicity
against HepG2 and HepG2.2.15 cells, accompanied with elevated
interferon gamma (IFN-γ) production. Similarly, enhanced cyto-
toxicity was also observed in PBMCs from CHB patients treated
with anti-Tim-3.
Conclusion: HBV infection upregulates Tim-3 expression on NK
cells, which may in turn suppress NK cell function during CHB.
OL-050 The study on the characters of HBV-speciﬁc T
cells and liver damage between HBeAg(+) and
HBeAg(–) CHB patients
Guoping Peng*,1, Wei Wu1, Xufei Tan1, Shuping Li 1,
Yiqiong Chen2, Zhi Chen1. 1National Key Laboratory of
Infectious Diseases, Institute of Infectious Diseases, First
Afﬁliated Hospital, Medical college, Zhejiang University;
2Institute of Immunology, Zhejiang University
Objectives: To study the quantity and quality of HBV-speciﬁc T
cells in chronic hepatitis B (CHB) patients with different HBeAg
status, and to investigate the extent of liver damage.
Methods: The serum HBV markers, liver damage, the frequency
and Foxp3 expression of CD4+CD25+ regulatory T cells (Treg),
and the expression levels of PD-1, CTLA-4 on HBV-speciﬁc T cells
were measured. HBV antigens speciﬁc T-cell responses, with or
without anti-PD-1 mAb and/or anti-CTLA-4 mAb blocking, were
also tested.
Results: The demographic characters, serum ALT levels, the fre-
quency and Foxp3 expression of Treg were similar between two
groups, and the serum HBV DNA levels were higher in HBeAg(+)
patients. The liver necroinﬂammation was comparatively severe
in HBeAg(–) patients (P=0.052), while the median percentage of
liver cirrhosis was much higher in HBeAg(+) patients. The differ-
ence of HBV-speciﬁc T-cell frequency was not signiﬁcant, whereas
the expression levels of PD-1 and CTLA-4 on HBV-pentamer(+)
T cells were higher in HBeAg(+) patients. Combined using of
anti-PD-L1 and anti-CTLA-4 mAb could signiﬁcantly increase the
cellular proliferation in both groups, and markedly enhanced the
IFN-γ production in HBeAg(+) patients.
Conclusion: The persistency of HBeAg could induce higher ex-
